Sysmex has announced the establishment of a new wholly owned subsidiary, Sysmex Greece IKE, as part of its strategic plan to enhance direct sales, customer care, and business development in Southern Europe.Sysmex has had a presence in Greece for over 30 years through partnerships and distributors. The decision to establish a local subsidiary marks a significant step in strengthening its European business infrastructure and aligning its operations more closely with customer needs in the region.
The new entity will enable Sysmex to offer direct sales and high-quality, standardised customer support in key diagnostic fields, including haemostasis, urinalysis, clinical flow cytometry (FCM), and life sciences. By delivering value-added solutions tailored to local market characteristics, Sysmex aims to reinforce its position in existing markets while laying the groundwork for expansion into emerging segments.
Greece’s healthcare system, underpinned by universal health insurance, is poised for growth amid demographic changes and a recovering economy. Sysmex sees this as an opportunity to provide advanced diagnostics and support improved patient outcomes in collaboration with local stakeholders.
“Establishing Sysmex Greece .KE reflects our commitment to deepening relationships with healthcare providers in the region,” said Kaoru Asano, President of Sysmex Corporation. “By strengthening our direct operations, we can better understand local challenges, deliver tailored solutions, and contribute meaningfully to the advancement of healthcare in Greece and beyond.”
This latest move follows a long-standing strategy by Sysmex to expand its footprint across Europe, dating back to its first European subsidiary in Germany in 1980. The company plans to continue investing in regional capabilities and cross-border synergies to accelerate innovation and access in diagnostics.
More information online